Propose ideas

Our Ideas Incubator allowed us to gather ideas for potential new call topics from the wider health and research community.


About the IHI Ideas Incubator

The concept of ‘co-creation’ is embedded in the way IHI works. When it comes to ideas for potential new call topics, this means that we welcomed suggestions from the wider health and research community. We set up the IHI Ideas Incubator to make it easier for people to submit proposals, and for IHI to assess them. 

Closure of the IHI Ideas Incubator

IHI will launch its final calls for proposals in early 2027 and discussions on the topics are already ongoing. We are therefore closing the Ideas Incubator. Ideas submitted before 14 September 2026 will still be assessed as set out below. However, it will no longer be possible to submit new proposals.

We would like to thank the many people who have submitted inspiring and innovative ideas which have enriched the IHI programme.

What happens to ideas submitted?

1 - Completeness and quality check

When you submit an idea, you’ll receive an automatic acknowledgement from the system with your idea’s reference number. On our side, IHI staff will first carry out a simple completeness and quality check, to ensure that the form contains enough information for review and that your idea is in line with IHI’s objectives. If your idea passes this check, it will go to the next stage (i.e. review by the IHI Science and Innovation Panel). If your idea does not pass this first check, you will receive an e-mail from the IHI Programme Office informing you of this and explaining the reasons behind the decision.

2 - Review by the IHI Science and Innovation Panel and publication online

Ideas that pass the first check are reviewed by the IHI Science and Innovation Panel (SIP), which is made up of experts from diverse sectors, disciplines and stakeholder groups. The SIP discusses the ideas at their meetings and agrees on which ideas merit further consideration, i.e. they are aligned with IHI’s objectives and have the potential to be developed further as all or part of an IHI call topic. The SIP sends its feedback on the ideas to the IHI Governing Board.

All ideas reviewed by the SIP are published here under the 'Ideas' tab above, along with the SIP opinion. This is for transparency purposes. Note that we do not inform idea submitters of the outcome of the SIP review or when their idea is published.

3 - Further development of ideas

Ideas that receive a positive review from the SIP are discussed by the IHI members and may be developed further as part of an IHI call topic. The topic development and approval process involves a wide range of stakeholders and all IHI governance bodies. This means that even if your idea is reviewed positively by the SIP, it may be altered significantly during the subsequent stages of topic development, or it could become a small part of a broader topic. It may also be dropped entirely.

If my idea is turned into a call topic, can I also be part of the project?

In practice, most external ideas taken on board by IHI are more likely to form just one component/aspect of a call topic. In any case, it is important to understand that if your idea is supported and ultimately used in an IHI call topic, the fact that you submitted the original idea does not give you any rights to participate in the resulting project or receive any IHI funding. If you want to be involved in the project, your options will depend on whether your topic is part of a single-stage or two-stage call, and whether or not you are willing to contribute to the project in kind. Note that not all organisations are eligible to receive IHI funding – further details can be found on our call documents page.

Single-stage calls: If your idea is part of a single-stage call topic, you will need to join / build a consortium and apply via our normal competitive call process. This is regardless of whether you want to receive IHI funding or whether you want to contribute to the project either as an industry partner or IHI contributing partner. Your proposal would be reviewed by independent experts alongside all other eligible proposals.

Two-stage calls for organisations that want to receive IHI funding: If your idea is part of a two-stage call topic, you will need to join / build a consortium and apply via stage 1 of our normal competitive call process. Your proposal would be reviewed by independent experts alongside all other eligible proposals.

Two-stage calls for organisations that are willing to contribute to the project in kind: If you are a member of one of IHI’s industry partners, or are (or are willing to become) an IHI contributing partner, you can be part of the pre-formed industry consortium that contributes to the definition of the topic and, crucially, contributes to the project in kind once it is up and running.


For transparency purposes, all ideas reviewed by the SIP are published here, along with a summary of the SIP opinion. Ideas are categorised by their current status (incorporated into a call topic / kept for consideration / not kept for consideration at this stage).

Incorporated into a call topic
Novel nuclear theranostics for personalised cancer diagnosis and care

Idea ref. 001173 | SIP opinion | Published on 03.04.2023
Elements of this idea were incorporated into IHI call 5 - topic 2 'Development and proof of principle of new clinical applications on theranostics solutions', which resulted in 3 projects: Accelerate.EU, ILLUMINATE, and Thera4Care.

Innovative enrichment strategies for mental disorders using objective, quantifiable and predictive biomarkers
Idea refs. 001219, 001221, 01222, 001223, 001224, 001225, 001226, 001230, 001231, 001232, 001233
SIP opinions | Published on 23.01.2025
Elements of this idea were incorporated into IHI call 11 - topic 1 'Towards precision medicine: platform for transdiagnostic stratification of brain dysfunction'.
Note: IHI received 11 almost-identical ideas from 11 separate organisations / individuals. As they are extremely similar, the SIP assessed them together and we are publishing the ideas and the SIP's opinion of them together.

Kept for consideration

Pan-European neurofibromatosis clinical trials network and data platform
Idea ref: 001296 | SIP opinion | Published on 08.05.2026

Leveraging EUDAMED for a federated hospital traceability and research ecosystem
Idea ref: 001303 | SIP opinion | Published on 08.05.2026

The IVD Quality Alliance (iQuAL) – establishing an EU-wide quality-monitoring metastructure for in-
vitro diagnostic medicine to support implementation of the IVDR

Idea ref. 001280 | SIP opinion | Published on 01.09.2025 

Replace, repair and regenerate oral tissues using medical devices with new and non-compromised chemistry and new digital techniques
Idea ref. 001215 | SIP opinion | Published on 29.04.2025

Enhancing EU competitiveness by integrating pragmatic trials and real-world evidence in precision oncology
Idea ref. 001244 | SIP opinion | Published on 29.04.2025

Improving the production and delivery of Advanced Therapy Medicinal Products (ATMP) and patient accessibility by supporting collaboration between academic laboratories and industry
Idea ref. 001228 | SIP opinion | Published on 11.02.2025

Harnessing data science and artificial intelligence to scale and democratize small molecule drug discovery
Idea ref. 001209 | SIP opinion | Published on 25.04.2024
Elements of this idea were incorporated into a proposal submitted under IHI call 9, a broad, applicant-driven call. The proposal was successful and the resulting project is LIGAND-AI.

Reducing the footprint of haemodialysis
Idea ref. 001204 | SIP opinion | Published on 25.04.2024

Multi cancer early detection - finding cancer in asymptomatic citizens
Idea ref. 001172 | SIP opinion | Published on 04.04.2023

A supportive framework for the introduction of medical technology for prevention, diagnosis, treatment and management of rare diseases
Idea ref. 001181 | SIP opinion | Published on 03.04.2023

Not kept for consideration at this stage

Developing protector cell and filtration-based cancer therapies
Idea ref. 001301 | SIP opinion | Published on 08.05.2026

A digital immune system
Idea ref. 001292 | SIP opinion | Published on 16.12.2025

Revolutionary cancer theory and quantum medicine: A translational approach for IHI's innovation
Idea ref. 001282 | SIP opinion | Published on 15.10.2025

From lab to life: driving innovation in reproductive medicine
Idea ref. 001277 | SIP opinion | Published on 15.10.2025

Advanced Health Prevention through Biomarker Measurement with Wearable Devices
Idea ref. 001235 | SIP opinion | Published on 05.05.2025

In vivo data redefined: Empowering drug discovery with advanced insights through the right data frameworks and standards
Idea ref. 001220 | SIP opinion | Published on 29.04.2025

Enabling precision medicine for psychiatric disorders in Europe through integrated real-world evidence data platform creation
Idea ref. 001229 | SIP opinion | Published on 11.02.2025

Advanced indoor air purifier utilizing genetically modified algae and bio-photovoltaic systems
Idea ref. 001227 | SIP opinion | Published on 11.02.2025

Creation of an artificial intelligence powered data platform to support the development of diagnostics and precision medicine for myalgic encephalomyelitis/ chronic fatigue syndrome (ME/CFS) and long COVID
Idea ref. 001211 | SIP opinion | Published on 25.04.2024

Objective clinical characterization and prediction of mental disorders evolution
Idea ref: 001208 | SIP opinion | Published on 25.04.2024

A standard protocol to share personal activity and medical data
Idea ref. 001207 | SIP opinion | Published on 25.04.2024

Anti-aging vaccine development
Idea ref. 001203 | SIP opinion | Published on 25.04.2024

Failure medicine data for further research - Building a consortium of patients, research institutes and industry
Idea ref. 001199 | SIP opinion | Published on 23.01.2024

Neuroelectronic medicine and the European health strategy
Idea ref. 001198 | SIP opinion | Published on 01.12.2023

Reconciling the technical and legal requirements of the European Health Data Space
Idea ref. 001169 | SIP opinion | Published on 12.12.2022

Improved care pathways in Parkinson’s disease through digital technologies
Idea ref. 001164 | SIP opinion | Published on 12.12.2022

Defining the temporal responsiveness of the gut microbiome to major diet and lifestyle interventions
Idea ref. 001160 | SIP opinion | Published on 12.12.2022